Document is current
Any future updates will be listed below
-
Authors
Smeijer, J. David
Kohan, Donald E.
Dhaun, Neeraj https://orcid.org/0000-0001-9128-6603
Noronha, Irene L.
Liew, Adrian https://orcid.org/0000-0002-0963-6270
Heerspink, Hiddo J. L. https://orcid.org/0000-0002-3126-3730
- License Information
-
More Information
Article History
Accepted: 30 October 2024
First Online: 6 December 2024
Competing interests
: D.E.K. has consulted for AstraZeneca, Chinook Therapeutics and Travere Therapeutics. N.D. has consulted for Travere Therapeutics. I.L.N. has received honoraria for scientific presentations from AstraZeneca, Bayer, Roche and Novartis. A.L. has consulted for DaVita Inc, Alnylam Pharmaceuticals, Baxter Healthcare, Bayer, Boehringer-Ingelheim, Chinook Therapeutics, Eledon Pharmaceuticals, George Clinical, Kira Pharmaceuticals, Otsuka Pharmaceuticals and ProKidney, and received honoraria from Alnylam Pharmaceuticals, AstraZeneca, Baxter Healthcare, Bayer, Boehringer-Ingelheim, Chinook Therapeutics and Otsuka Pharmaceuticals. H.J.L.H. has consulted for AstraZeneca, Bayer, Boehringer Ingelheim, Chinook, CSL Behring, Dimerix, Eli-Lilly, Gilead, Janssen, Merck, Novo Nordisk, ProKidney, Travere Therapeutics and Vifor Fresenius, and received research support from AstraZeneca, Boehringer Ingelheim, Janssen and Novo Nordisk. J.D.S. has no competing interests.
